Every SEC Form 3/4/5 on record for this filer (CIK 1247015) — 10 issuers, 56 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Director | 2018-01-02 → 2026-06-08 | 23 | $2M |
| NEXI | NexImmune, Inc. | Director · lapsed | 2021-02-11 → 2023-07-07 | 14 | $2M |
| CFRX | CONTRAFECT Corp | Director · lapsed | 2016-05-10 → 2022-05-18 | 9 | $49,600 |
| CERC | Cerecor Inc. | Director · lapsed | 2020-02-05 → 2021-06-17 | 4 | — |
| GNMX | Aevi Genomic Medicine, Inc. | Director · lapsed | 2017-04-27 → 2020-02-05 | 9 | $3M |
| EDGE | Edge Therapeutics, Inc. | Director · lapsed | 2015-09-30 → 2019-03-18 | 8 | $495,000 |
| NSPR | InspireMD, Inc. | Director · lapsed | 2015-07-02 → 2016-12-08 | 8 | $500,000 |
| AEGR | Aegerion Pharmaceuticals, Inc. | Director · lapsed | 2016-11-30 → 2016-11-30 | 1 | — |
| FOLD | AMICUS THERAPEUTICS INC | Director · lapsed | 2016-06-13 → 2016-06-13 | 1 | — |
| MDGN | MEDGENICS, INC. | Director · lapsed | 2015-10-08 → 2016-04-19 | 2 | $999,999 |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| NEXI | 2023-03-30 | Buy | 400,000 | $0.41 | $164,000 | 2,217,814 |
| NEXI | 2022-11-17 | Buy | 75,000 | $0.48 | $36,000 | 1,817,814 |
| NEXI | 2022-11-16 | Buy | 125,000 | $0.48 | $60,000 | 1,742,814 |
| NEXI | 2022-06-02 | Buy | 20,720 | $2.22 | $45,998 | 1,617,814 |
| NEXI | 2022-06-01 | Buy | 40,000 | $2.35 | $94,000 | 1,597,094 |
2 of 10 issuers are covered and open a security page; the rest are on file here only.
